ArticleExploratory research in clinical and social pharmacy2022
Community pharmacists' experiences of working during lockdown.
Article in Exploratory research in clinical and social pharmacy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Community pharmacy services during the COVID-19 pandemic: Insights from providers and policy makers.Exploratory research in clinical and social pharmacy · 2023Article
- Associations between self-reported healthcare disruption due to covid-19 and avoidable hospital admission: evidence from seven linked longitudinal studies for England.BMJ (Clinical research ed.) · 2023Observational
- The "affected" pharmacist and the "business as usual" pharmacist: Exploring the experiences of pharmacists during COVID-19 through cluster analysis.Journal of the American Pharmacists Association : JAPhAArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTransmission of the novel coronavirus strain, SARS-CoV-2, caused many health services to reach crisis points worldwide. As infection rates rose, many countries implemented 'lockdown' periods where only essential services could remain open; this included community pharmacies in the UK. This study retrospectively explores the experiences of community pharmacists during the first lockdown period of the pandemic in the UK, helping us to learn for the future if another pandemic were to arise.
objectiveThe objectives of this study were to explore the main professional and personal worries and concerns that pharmacists experienced during the first UK lockdown. Key practical issues specific to COVID-19 were investigated: staffing levels, precautionary measures undertaken, workload issues, medicines shortages, support, and guidance. In addition, the perceived effectiveness of support available to community pharmacists was examined.
methodsCommunity pharmacists in the Stoke-on-Trent and Staffordshire regions of the UK were invited to participate in a semi-structured telephone interview. Participants were recruited until no new themes emerged. Interviews were transcribed verbatim, and thematic analysis was undertaken using the Framework Approach.
resultsIn total, 29 community pharmacists were interviewed across Stoke-On-Trent and Staffordshire, with interviews lasting on average for 20 min. Fifteen interviewees were from independent pharmacies and 14 from large-chain pharmacies. Five themes emerged from the data: difficulty maintaining staffing levels; precautionary measures undertaken for staff and patients; increase in dispensing volume; dealing with medicines shortages; and perceptions of support varied, with guidance reported to be initially slow and conflicting.
conclusionOverall, this study highlights the crucial role that community pharmacists in the UK played in ensuring patients still received their medication and health advice, despite the challenging circumstances in which they found themselves. Community pharmacies need appropriate support, recognition, and funding to enable them to remain sustainable and continue to provide a critical service in the face of possible future pandemics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.